Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-beta via a nuclear factor 1-binding element
about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansEndorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonismEndorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cellsInvolvement of activator protein 1 complexes in the epithelium-specific activation of the laminin gamma2-chain gene promoter by hepatocyte growth factor (scatter factor)Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscleAntisense targeting of perlecan blocks tumor growth and angiogenesis in vivoPerlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis.Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: evidence for a protective role for glucosamine in atherosclerosis.The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagyHeparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complicationsDevelopmental expression of perlecan during murine embryogenesisTranscriptional silencing of perlecan gene expression by interferon-gammaBiomarker discovery from pancreatic cancer secretome using a differential proteomic approachModulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-mediated transcriptional activation of TGFbeta2A current view of perlecan in physiology and pathology: A mosaic of functions.Endorepellin evokes autophagy in endothelial cellsTranscriptional activation by NFκB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironmentExtracellular deposition of matrilin-2 controls the timing of the myogenic program during muscle regeneration.Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition.Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathyPerlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia.The interplay of extracellular matrix and microbiome in urothelial bladder cancer.Endorepellin affects angiogenesis by antagonizing diverse vascular endothelial growth factor receptor 2 (VEGFR2)-evoked signaling pathways: transcriptional repression of hypoxia-inducible factor 1α and VEGFA and concurrent inhibition of nuclear factEndostatin and endorepellin: A common route of action for similar angiostatic cancer avengersProteoglycans in cancer biology, tumour microenvironment and angiogenesis.Matrix-dependent plasticity of the malignant phenotype of bladder cancer cells.NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression.Nuclear factor I-C is essential for odontogenic cell proliferation and odontoblast differentiation during tooth root development.Nuclear factor I-C links platelet-derived growth factor and transforming growth factor beta1 signaling to skin wound healing progression.Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue bordersSkeletal dysplasias associated with mild myopathy-a clinical and molecular review.Small leucine rich proteoglycan family regulates multiple signalling pathways in neural development and maintenance.Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: a role in angiogenesis and wound healing.Three activator protein-1-binding sites bound by the Fra-2.JunD complex cooperate for the regulation of murine laminin alpha3A (lama3A) promoter activity by transforming growth factor-beta.Endorepellin-evoked Autophagy Contributes to Angiostasis.The heparin-binding site of antithrombin is crucial for antiangiogenic activityPerlecan heparan sulfate proteoglycan: a novel receptor that mediates a distinct pathway for ligand catabolism.Regulatory activities of the 5'- and 3'-untranslated regions and promoter of the human aggrecan gene.Perlecan: an important component of the cartilage pericellular matrix.Promoter regulatory elements and DNase I-hypersensitive sites involved in serglycin proteoglycan gene expression in human erythroleukemia, CHRF 288-11, and HL-60 cells.
P2860
Q21710680-097B5E8E-BEBF-44DF-88BD-E7FCC7D9AC02Q24303934-E6E5E17A-2CC9-42EE-9EB0-C8F40B253E70Q24312922-FB2F3148-54CF-45C8-A145-1D7DA5766BDFQ24532012-BAE7C713-3149-46E5-B03E-B378E1900A28Q24538577-9C367E0F-B0A2-47AA-8C2C-617A4E149270Q24564477-90311701-4A67-4BAD-AB69-4F31E3820533Q24653433-72F43012-A610-4CD5-97F1-F4C71BBB1C62Q24813839-2C5511DA-927C-496A-8DAD-46A970C0E96CQ26800258-CCAF2A9B-8ED6-4506-8CD7-FC97CB1013A1Q28213716-03E09AF5-5405-40FA-BF83-9682FC3C7BB6Q28251854-A376E020-FE35-4A6C-8698-5753C44811D6Q28262244-3C38E489-A562-4A40-ADDD-0A5C7AB5C274Q28276398-6F6C1170-56BC-49DF-B0E6-D59E0FF483AEQ28507487-E6A516B9-4BD0-46C8-A6C8-E4935E51588CQ30392738-CA83017D-3F66-4EAE-B296-4497E5A2BBA0Q33718473-8C7E9288-1B74-428B-93C5-998D80F8390EQ33882116-76E92363-B86D-461B-8060-FB797B230068Q33980534-042A178B-20E3-405A-9C1F-F99AF930AF48Q34126666-B89BB7DC-2C5E-401A-BE66-7678838C22FEQ34563204-AB6186B7-AC5A-4150-A2F2-9F8BB2F84073Q35799754-E15F22DF-08D6-459B-BFA4-D73CB50C0F90Q35868405-341FDC47-407B-4577-996B-63B2CC1DE0DDQ36481790-C1923E10-2206-4AE0-AA45-4E203BF646EDQ36578668-B530FC10-D47C-405B-B8F9-0F6C677EE013Q36787608-F7BA7AD5-0000-4C55-83B0-D204AA5F5B23Q36922877-7C3A9BA9-83FF-47F5-AE0D-D9ACEF2069D7Q37093403-922737FF-AA8F-40E7-AEF5-A2B0B0E3E226Q37285177-E0EA60EA-FA72-4413-A305-2829C1C226E7Q37410414-7B087E6C-B7F3-446E-950C-8AD5D80915E6Q37610826-8F0A6271-F2A2-4915-AEDA-D79EFE2253ACQ37761307-9FE69D61-E0DA-4796-B30D-A24C023FB17AQ38004614-EEAD27ED-91EA-4405-A90C-0F02506E5015Q39227219-7BB538A6-E735-4979-8FDC-A4177F8208E9Q41028672-DD71DBC4-415D-4C2D-BC74-8E53AA83C537Q41049426-FA0F8101-E2E3-45A9-9044-8913D196FBA6Q41845994-216CE9D5-0E71-40E9-A962-ED86BC3B9930Q41921681-19911F8C-B1A9-4707-AEA0-EBBD57CFE945Q42831293-D009A68B-B0DB-462B-9AFA-F177EC3BF19EQ43229719-BE7DD5FB-C6DF-4DD4-B975-A27C7B299DDBQ43595440-19A844B8-D52A-461F-8B1D-3CB6FE9B8DBD
P2860
Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-beta via a nuclear factor 1-binding element
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Structural and functional char ...... clear factor 1-binding element
@ast
Structural and functional char ...... clear factor 1-binding element
@en
Structural and functional char ...... clear factor 1-binding element
@nl
type
label
Structural and functional char ...... clear factor 1-binding element
@ast
Structural and functional char ...... clear factor 1-binding element
@en
Structural and functional char ...... clear factor 1-binding element
@nl
prefLabel
Structural and functional char ...... clear factor 1-binding element
@ast
Structural and functional char ...... clear factor 1-binding element
@en
Structural and functional char ...... clear factor 1-binding element
@nl
P2093
P2860
P356
P1476
Structural and functional char ...... clear factor 1-binding element
@en
P2093
A D Murdoch
J Pillarisetti
K G Danielson
P2860
P304
P356
10.1074/JBC.272.8.5219
P407
P577
1997-02-01T00:00:00Z